Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma.

MLA

Puertas, Borja, et al. “Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma.” Cancers, vol. 15, no. 5, Mar. 2023. EBSCOhost, https://doi.org/10.3390/cancers15051558.

APA

Puertas, B., González-Calle, V., Sobejano-Fuertes, E., Escalante, F., Queizán, J. A., Bárez, A., Labrador, J., Alonso-Alonso, J. M., García de Coca, A., Cantalapiedra, A., Villaescusa, T., Aguilar-Franco, C., Alejo-Alonso, E., Rey-Bua, B., López-Corral, L., García-Sanz, R., Puig, N., Gutiérrez, N. C., & Mateos, M.-V. (2023). Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma. Cancers, 15(5). https://doi.org/10.3390/cancers15051558

Chicago

Puertas, Borja, Verónica González-Calle, Eduardo Sobejano-Fuertes, Fernando Escalante, José A Queizán, Abelardo Bárez, Jorge Labrador, et al. 2023. “Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma.” Cancers 15 (5). doi:10.3390/cancers15051558.